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Introduction

Imaging Findings

● Throughout admission, his blood glucose remained
variable, but was responsive to increasing doses of
basal and rapid-acting insulin. Serum sodium
remained unchanged.
● Neurology recommended high dose IV thiamine
● Clinically, his mental status returned to baseline
and his dysarthria and ataxia gradually and mildly
improved over the course of his three-day
admission.
● At discharge, he still could not walk independently
and his speech remained slightly dysarthric.
● Patient attended two physical therapy sessions
outpatient and appeared to be improving, but had
two incidents of falls when not using his walker.

● Osmotic demyelination syndrome (ODS) is wellknown to occur in response to rapid correction of
hyponatremia.
● Symptoms of ODS are usually delayed 2-6 days
following the rapid serum sodium correction, and
may include dysarthria, dysphagia, extremity
weakness or paralysis, behavioral disturbances,
confusion seizures, lethargy, obtundation, and
coma.
● Patients with ODS typically present with with initial
serum sodium concentrations less than 120 mEq/L.
In extremely rare scenarios, ODS may result from
other serum osmolar abnormalities.
● We present one such example - ODS in a Type 2
diabetic with chronic, severe hyperglycemia.

Discussion

Case Presentation
● A 36 year old male with poorly controlled type 2
diabetes mellitus (A1c of 15.7%) on metformin,
insulin, and empagliflozin presented to the
emergency department with unstable gait,
dysarthric speech, anomia, confusion, and
asymmetric weakness.
● Vitals signs stable. Physical examination revealed
left-sided weakness, slurred speech, and abnormal
cerebellar testing.
● Head CT was negative for stroke.
● Lab workup demonstrated blood glucose 490, lactic
acid 3.7, bicarbonate 24, and anion gap 14.
● Serum sodium, corrected for blood glucose 141.

Case Resolution

Figure 1. MRI Brain W & WO Contrast
Amorphous restricted diffusion and FLAIR signal hyperintensity within
the central pons without significant pontine expansion or postcontrast
enhancement. Pattern is suggestive of osmotic demyelination (central
pontine myelinolysis). Other metabolic abnormalities such as
hyperglycemia-related edema or acute hypertensive encephalopathy
are not excluded, although brainstem predominant pattern is less
common in these entities.
Figure 2.
Pathophysiology of ODS

Attribution: Crismale et al. 2017

● There are only a handful of documented cases
reporting ODS in patients with stable serum
sodium and hyperglycemia; nearly all cases are
associated with Hyperosmolar Hyperglycemic State
or blood glucose >600.
● The exact pathophysiologic mechanism of the
relationship between high serum glucose and
pontine demyelination is not clearly understood,
but a possible explanation involves hypertonic
pontine insult resulting in injured astrocytes,
disruption of the astrocyte-oligodendrocyte
network, and induced apoptosis.
● Management should involve frequent neurologic
examinations, treatment of hyperglycemia, and
physical rehabilitation. This case provides evidence
that severe hyperglycemia can cause ODS.
● Recovery from hyperglycemia-induced ODS
appears to be good overall. Ataxia may be a
persistent feature and affect functional status.
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